Capital Fund Management S.A. Trims Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Capital Fund Management S.A. lowered its stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 80,984 shares of the company's stock after selling 3,924 shares during the period. Capital Fund Management S.A. owned approximately 0.27% of Inspire Medical Systems worth $15,013,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. First Horizon Advisors Inc. grew its holdings in shares of Inspire Medical Systems by 885.7% in the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock worth $26,000 after purchasing an additional 124 shares during the last quarter. Huntington National Bank boosted its stake in shares of Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock valued at $32,000 after purchasing an additional 121 shares in the last quarter. Harbour Investments Inc. raised its position in shares of Inspire Medical Systems by 101.0% in the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after acquiring an additional 99 shares in the last quarter. AlphaQuest LLC lifted its position in Inspire Medical Systems by 7,275.0% during the fourth quarter. AlphaQuest LLC now owns 295 shares of the company's stock valued at $55,000 after buying an additional 291 shares during the period. Finally, Quadrant Capital Group LLC boosted its stake in Inspire Medical Systems by 61.9% during the fourth quarter. Quadrant Capital Group LLC now owns 327 shares of the company's stock worth $61,000 after acquiring an additional 125 shares in the last quarter. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Inspire Medical Systems Stock Down 2.1 %

NYSE INSP traded down $3.11 on Tuesday, reaching $146.59. The company had a trading volume of 273,201 shares, compared to its average volume of 589,905. The stock has a market capitalization of $4.36 billion, a PE ratio of 84.73, a price-to-earnings-growth ratio of 2.86 and a beta of 1.39. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The firm's 50 day moving average price is $168.82 and its 200 day moving average price is $184.75.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, research analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Analysts Set New Price Targets

INSP has been the subject of several recent analyst reports. Royal Bank of Canada decreased their target price on shares of Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday. Stifel Nicolaus decreased their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating for the company in a research note on Tuesday, January 21st. KeyCorp reiterated an "overweight" rating and issued a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Wells Fargo & Company cut their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 11th. Finally, Truist Financial decreased their price objective on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a research note on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Inspire Medical Systems presently has an average rating of "Moderate Buy" and a consensus price target of $222.20.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Randy Ban sold 25,584 shares of the firm's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares of the company's stock, valued at $1,332,026.50. This trade represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.